CAMK2G and cancer: Since CAMKII activity relies on Ca2+ profiles, perhaps targeting Ca2+ oscillation-generating channels and transporters represents a therapeutic pathway to reconstitute normal epigenetic patterns in cancer cells, albeit further research is required to address these issues.